|
EP0021000A3
(en)
*
|
1979-05-23 |
1981-12-02 |
F. Hoffmann-La Roche & Co. Aktiengesellschaft |
Substituted acetophenones, their preparation, their application and pharmaceutical compositions containing them
|
|
US4327088A
(en)
|
1979-05-23 |
1982-04-27 |
Hoffmann-La Roche Inc. |
Phosphonooxy- or glycosyloxy-substituted acrylophenones, compositions and uses thereof
|
|
EP0021000A2
(de)
*
|
1979-05-23 |
1981-01-07 |
F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
Substituierte Acetophenone, deren Herstellung und pharmazeutische Präparate, die sie enthalten
|
|
EP0540143A2
(en)
*
|
1991-08-02 |
1993-05-05 |
Medivir Aktiebolag |
Compounds and methods for inhibition of HIV and related viruses
|
|
EP0540143A3
(es)
*
|
1991-08-02 |
1995-01-04 |
Medivir Ab |
|
|
US5593993A
(en)
*
|
1991-08-02 |
1997-01-14 |
Medivir Ab |
Method for inhibition of HIV related viruses
|
|
US5658907A
(en)
*
|
1991-08-02 |
1997-08-19 |
Medivir A/B |
Compounds and methods for inhibition of HIV and related viruses
|
|
US5714503A
(en)
*
|
1991-08-02 |
1998-02-03 |
Medivir Ab |
Compounds and methods for inhibition of HIV and related viruses
|
|
US8455652B2
(en)
|
2003-04-03 |
2013-06-04 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Inhibitors for the soluble epoxide hydrolase
|
|
US8476043B2
(en)
|
2004-10-20 |
2013-07-02 |
The Regents Of The University Of California |
Inhibitors for the soluble epoxide hydrolase
|
|
WO2007017764A3
(en)
*
|
2005-05-18 |
2007-07-05 |
Neuraxon Inc |
Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity
|
|
US7919510B2
(en)
|
2005-05-18 |
2011-04-05 |
Neuraxon, Inc |
Substituted benzimidazole compounds with dual NOS inhibitory activity and mu opioid agonist activity
|
|
US8188289B2
(en)
|
2006-03-13 |
2012-05-29 |
The Regents Of The University Of California |
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
|
|
AU2007225170B2
(en)
*
|
2006-03-13 |
2012-11-01 |
The Regents Of The University Of California |
Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
|
|
WO2007106525A1
(en)
*
|
2006-03-13 |
2007-09-20 |
The Regents Of The University Of California |
Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
|
|
US8501783B2
(en)
|
2006-03-13 |
2013-08-06 |
The Regents Of The University Of California |
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
|
|
US9029550B2
(en)
|
2006-03-13 |
2015-05-12 |
The Regents Of The University Of California |
Conformationally restricted urea inhibitors of soluble epoxide hydrolase
|
|
US9296693B2
(en)
|
2010-01-29 |
2016-03-29 |
The Regents Of The University Of California |
Acyl piperidine inhibitors of soluble epoxide hydrolase
|